`
`IPR2018-00120
`
`Page 1 of 2
`
`I-MAK 1011
`
`
`
`296 PRELIMINARY NOTES VOL. 32 (1959) from each other by paper chromatography employing the ethyl acetate-phosphate buffer system 6 (Table II). Insertion of the iodine atom into the molecule results in a marked increase in the mobility of each of the pyrimidine derivatives; however, there is no alteration in the order of migration. Iododeoxyuridine may also be synthesized by a modification of the method of JOHNSON AND JOHNS 7 for iodouracil. Deoxyuridine (228 mg), iodine (250 mg), and NaOH (3 N, 2 ml) were heated on a steam bath for 15 min; after dilution with water (50 ml) the solution was passed through a Dowex-I-formate column. After washing the column with NaOH (o.oi N) until no iodide appeared in the effluent, as indicated by reaction with AgN08, elution was continued with formic acid (o.I N). Immediately after the elution of unreacted deoxyuridine, iododeoxyuridine appeared. TABLE Ii RF VALUES OF SOME DERIVATIVES OF URACIL AND IODOURACIL Solvent: Ethyl acetate saturated with phosphate buffer (o.o5 M, pH 6.0). Compound R F Iodouracil o. 75 Uracil o. 21 Iododeoxyuridine 0.67 Deoxyuridine o. i 2 Iodouridine 0.44 Uridine 0.06 In contrast to iodouridine, iododeoxyuridine is almost as effective as iodouracil as an inhibitor of the growth of Streptococcus [aecalis (ATCC 8o43), when grown in media supplemented with thymine, thymidine or pteroylglutamic acid. With mouse Ehrlich ascites carcinoma cells in vitro, iododeoxyufidine but not iodouracil or iodouridine reversibly inhibited the utilization of 14C-labeled thymidine for the bio- synthesis of DNA-thymine. Iododeoxyuridine inhibited markedly the utilization of [14C]orotic acid or [a4C]forrnate for the biosynthesis of DNA-thymine, but not of [a4C] orotic acid for the biosynthesis of DNA-cytosine or RNA pyrimidines. Hence the mechanism of action of iododeoxyuridine would appear to be an inhibition of the utilization of a thymine-containing precursor of DNA-thymine. Details of the bio- logical studies will appear elsewhere. This investigation was supported by a grant (CY-3o76) from the National Institutes of Health, U.S. Public Health Service. Department o~ Pharmacology Yale University, School o/ Medicine, New Haven, Conn. (U.S.A.) WILLIAM H. PRUSOFF 1 w. H. PRUSOFF, W. L. HOLMES AND A. D. WELCH, Cancer Research, 13 (1953) 22i. 2 G. H. HITCHINGS, E. A. FALCO AND M. B. SHI~RWOOD, Science, lO2 (1945) 251. 8 S. ZAMENHOF, B. RlglNER, R. DEGIOVANNI AND K. RICH, J. Biol. Chem., 219 (1956) 165. 4 D. B, DUNN AND J. D. SMITH, Biochem. J., 67 (1957) 494; Nature, 174 (1954) 305. 5 M. FRIEDKIN AND D. ROBERTS, J. Biol. Chem., 2o 7 (1954) 257. * W. H. PRUSOFF, J. Biol. Chem., 215 (1955) 809. 7 T. B. JohNsoN AND C. O. JOHNS, J. Biol. Chem., I (I905-O6) 305 . Received November 2oth, 1958
`
`IPR2018-00120
`
`Page 2 of 2
`
`I-MAK 1011
`
`